Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

OBJECTIVE: The clinical benefit of ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) has never been reported in absolute measures. The aim of this study was to assess the number needed to treat (NNT) with UDCA to prevent liver transplantation (LT) or death among patients with PBC. MET...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut
Autors principals: Harms, Maren H, de Veer, Rozanne C, Lammers, Willem J, Corpechot, Christophe, Thorburn, Douglas, Janssen, Harry L A, Lindor, Keith D, Trivedi, Palak J, Hirschfield, Gideon M, Pares, Albert, Floreani, Annarosa, Mayo, Marlyn J, Invernizzi, Pietro, Battezzati, Pier Maria, Nevens, Frederik, Ponsioen, Cyriel Y, Mason, Andrew L, Kowdley, Kris V, Hansen, Bettina E, van Buuren, Henk R, van der Meer, Adriaan J
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Hepatology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398464/
https://ncbi.nlm.nih.gov/pubmed/31843787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-319057
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars